Zimmer Biomet Appoints Chintan Desai as Asia Pacific President
Zimmer Biomet Holdings, Inc., recognized globally as a leader in medical technology, has just made a significant leadership change, appointing Chintan Desai as the president of its Asia Pacific Region, effective immediately. This appointment comes as the company aims to strengthen its presence in a crucial market with vast potential.
Chintan Desai is no stranger to the world of MedTech. His nearly thirty years of experience in leadership roles within respected companies give him a wealth of knowledge and expertise tailored to the unique dynamics of the Asia Pacific region. Ivan Tornos, Chairman and CEO of Zimmer Biomet, expressed confidence in Desai, highlighting his profound understanding of the market and strong leadership abilities. Tornos stated, "Chintan knows this market, he knows how to lead, and he will be a strong addition to our team. I'm very much looking forward to the impact he'll make."
Before joining Zimmer Biomet, Desai held a prominent position at Alcon, where he was responsible for international growth and export markets as the Vice President and General Manager. His tenure at Alcon saw him work closely with the International Leadership Team based in Switzerland, laying the groundwork for enhanced business strategies in diverse markets around the globe. Desai’s exceptional experience extends to his previous role as Vice President of Alcon's Asia Pacific Surgical business, based in Singapore, where he led efforts across multiple local markets.
Desai's extensive background includes over 22 years at GE Healthcare, where he has held several senior business leadership roles in the United States, Singapore, and Australia. This broad experience has equipped Desai with comprehensive skills encompassing sales management, marketing, supply chain logistics, and project management across a wide spectrum of medical-device functions.
Chintan Desai is also a certified Chartered Accountant from India, showcasing his robust grounding in finance—a critical asset for leading any regional operations. Additionally, he has completed the Executive Leadership Development Program at the prestigious Kellogg School of Management, further solidifying his qualifications as an executive leader.
Not only is Desai committed to his professional growth, but he also dedicates his time as a volunteer and mentor for business students and aspiring startups in the Asia Pacific, reflecting his passion for nurturing the next generation of leaders.
His appointment succeeds Sang Yi, the current Group President of the Asia Pacific, who announced his departure for transition planning on August 28. On behalf of the Zimmer Biomet team, Tornos expressed profound gratitude for Sang’s contributions over the past 13 years, which he acknowledged as instrumental in driving growth and advancing the company’s strategic aims across the Asia Pacific region.
As Zimmer Biomet continues to evolve, the company remains focused on optimizing patient experiences through innovative products, integrated digital solutions, and advanced robotic technologies. With more than 90 years of expertise in the medical technology landscape, they are well-positioned to navigate future challenges and opportunities. The appointment of Desai marks an important step in solidifying Zimmer Biomet's growth strategy, aligning with their mission to improve health and mobility for their patients across the globe.
For those interested in learning more about Zimmer Biomet's offerings or joining their mission, further information is available on their
official website and through their social media channels.